Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
Laura Sutcliffe
Laura Sutcliffe
Stock Analyst at UBS
(1.39)
# 3,101
Out of 4,683 analysts
4
Total ratings
66.67%
Success rate
-8.79%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology
Stocks Rated by Laura Sutcliffe
Stock
Action
Price Target
Current
Upside
Ratings
Updated
TLX
Telix Pharmaceuticals
Initiates:
Buy
$21
$16.19
+29.71%
1
Nov 15, 2024
ARGX
argenx SE
Initiates:
Buy
$390
$606.47
-35.69%
1
Jun 18, 2021
GLPG
Galapagos NV
Downgrades:
Neutral
n/a
$27.49
-
2
Dec 20, 2019
TLX
Telix Pharmaceuticals
Nov 15, 2024
Initiates:
Buy
Price Target:
$21
Current: $16.19
Upside:
+29.71%
1 Ratings
View All
ARGX
argenx SE
Jun 18, 2021
Initiates:
Buy
Price Target:
$390
Current: $606.47
Upside:
-35.69%
1 Ratings
View All
GLPG
Galapagos NV
Dec 20, 2019
Downgrades:
Neutral
Price Target:
n/a
Current: $27.49
Upside: -
2 Ratings
View All